Patients with Human Papillomavirus-associated Head and Neck Cancer for the Discovery of Predictive Biomarkers to Guide Clinical Intervention
NCT06821243 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 40
Last updated 2025-02-11
Summary
Prospective pilot study, non-interventional, of a biological/radiological nature, which involves the collection of tissue samples, and blood from patients suffering from squamous cell carcinoma of the oropharynx OPSCC for detection of HPV-DNA/RNA and immuno-phenotypic analysis of T cells, study of extracellular vesicles, and dosages of cytokines and chemokines involved in the immune response
Conditions
- Squamous Cell Carcinoma of Oropharynx
Sponsors & Collaborators
-
Università della Campania Luigi Vanvitelli
collaborator UNKNOWN -
Università di Napoli Federico II
collaborator UNKNOWN -
I.R.C.C.S. Fondazione Santa Lucia, Italy
collaborator UNKNOWN -
Regina Elena Cancer Institute
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2024-07-24
- Primary Completion
- 2026-07-24
- Completion
- 2026-07-24
Countries
- Italy
Study Locations
More Related Trials
-
Study of Taxotere, Cisplatin, 5-Fluorouracil, and Leucovorin for Squamous Cell Carcinoma of the Head and Neck
NCT00139243 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Identification of Predictive Factors for the Response to Anti-Programmed Cell Death Protein 1 (PD1) Immunotherapy in Head and Neck Squamous Cell Carcinoma
NCT05328024 ·Status: RECRUITING
-
De-intensification of Radiation & Chemotherapy in Low-Risk Human Papillomavirus-related Oropharyngeal Squamous Cell Ca
NCT01530997 ·Status: COMPLETED ·Phase: PHASE2
-
Cell-free Tumor DNA in Head and Neck Cancer Patients
NCT03942380 ·Status: UNKNOWN ·Phase: NA
-
Docetaxel/Cisplatin/5-Fluorouracil (TPF) Human Papillomavirus (HPV) Squamous Cell Carcinoma Study
NCT01221753 ·Status: TERMINATED ·Phase: PHASE2
-
Swallowing Outcomes and Circulating Tumor DNA in Patients With HPV Related Oropharyngeal Cancer Treated With Transoral Surgery and Reduced Intensity Adjuvant Therapy
NCT04920344 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Pilot Study of Chemotherapy for HPV-Associated Oropharyngeal Cancer
NCT04572100 ·Status: COMPLETED ·Phase: PHASE1
-
De-escalated Radiation for Human Papillomavirus-Positive Squamous Cell Carcinoma of the Oropharynx
NCT05600842 ·Status: RECRUITING
-
Major De-escalation to 30 Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma
NCT03323463 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
P53 Mutational Status and cf HPV DNA for the Management of HPV-associated OPSCC
NCT03077243 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Reduced Radiation Therapy and Standard-of-Care Chemotherapy in People With HPV-Positive Throat Cancer
NCT05491512 ·Status: RECRUITING ·Phase: PHASE2
-
A New Mutational and Epigenetic Signature to Predict Early OPSCC Relapse
NCT06138483 ·Status: RECRUITING
-
De-escalation of Adjuvant Radio (Chemo) Therapy for HPV-positive Head-neck Squamous Cell Carcinomas
NCT03396718 ·Status: RECRUITING ·Phase: NA
-
Phase II Treatment Stratification Trial Using Neck Dissection-Driven Selection to Improve Quality of Life for Low Risk Patients With HPV+ Oropharyngeal Squamous Cell Cancer
NCT02784288 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Reduced Radiation Therapy With Chemotherapy in People With HPV-Positive Throat Cancer
NCT06984861 ·Status: RECRUITING ·Phase: PHASE2
-
Node Positive Cervical Cancer Treated by Neoadjuvant Chemotherapy Plus Radical Surgery: a Single Center Experience
NCT06752135 ·Status: TERMINATED
-
RBD-HPV: Risk-Based De-Intensification for HPV+ HNSCC
NCT04849377 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study on Using Cell-Free Tumor DNA (ctDNA) Testing to Decide When to StartRoutine Treatment in People With Human Papilloma Virus (HPV)- Associated Oropharynx Cancer (OPC)
NCT05307939 ·Status: RECRUITING ·Phase: PHASE2
-
Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
NCT04900623 ·Status: RECRUITING ·Phase: PHASE2
-
Radiotherapy, Carboplatin/Paclitaxel and Nivolumab for High Risk HPV-related Head and Neck Cancer
NCT03829722 ·Status: COMPLETED ·Phase: PHASE2
-
Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer
NCT02048020 ·Status: COMPLETED ·Phase: PHASE2
-
Response-Adaptive Treatment in Untreated Locoregional HPV-Negative Head and Neck Cancer
NCT07065630 ·Status: RECRUITING ·Phase: PHASE2
-
Role of Immune Activation in Response of Head and Neck Squamous Cell Carcinoma to Therapy
NCT01358097 ·Status: COMPLETED
-
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer
NCT01898494 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Treatment of Patients With Locally Advanced Squamous Cell Carcinoma of the Head and Neck
NCT01086826 ·Status: COMPLETED ·Phase: PHASE3